BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 25, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Jan. 14, 2013
View Archived Issues
Novartis prepares new protein kinase inhibitors
Read More
Initial results available from phase I/II study of indibulin in metastatic breast cancer
Read More
Iron chelator ameliorates experimental Alzheimer's disease
Read More
French scientists design novel DCL enzyme inhibitors
Read More
Merck & Co. presents new mGlu2 receptor agonists
Read More
U.S. scientists divulge novel cytochrome P450 1A2 inducers
Read More
Metabolex presents new GPBA receptor agonists
Read More
Novel compounds for autoimmune disorders patented
Read More
Ultragenyx inlicenses triheptanoin from Baylor Research Institute
Read More
BIKAM Pharmaceuticals prepares new opsin-2 ligands
Read More
Esperion's ETC-1002 lowers LDL cholesterol in phase II trial
Read More
GeoVax completes enrollment in phase I/II trial for HIV/AIDS vaccine
Read More
Dosing completed in phase III BromSite study
Read More
Phase II trial of NeoFuse stem cell product meets endpoints
Read More
Novel drug-eluting bioadhesive gel reduces inflammation in atherosclerotic plaques in vivo
Read More
Morphotek discloses results from phase III study in platinum-sensitive epithelial ovarian cancer
Read More
KaloBios begins phase II study of Humaneered PEGylated monoclonal antibody fragment
Read More
Topline data reported from phase II study of tivantinib in colorectal cancer
Read More
MSD suspends availability of Tredaptive
Read More
Evotec advances compound into preclinical development under collaboration with Ono
Read More
Mirabegron approved in Europe
Read More
European Commission approves use of Zytiga earlier in the treatment cycle
Read More
Biota synthesizes promising inhibitor of cell division protein FtsZ
Read More
FDA grants orphan drug designation to Telik's investigational treatment for MDS
Read More